ONCOFID-P-B (Paclitaxel-Hyaluronic Acid) In The Intravesical Therapy Of Patients With Non-Muscle Invasive Cancer Of The Bladder. A Phase II Marker Lesion Study.
Phase of Trial: Phase II
Latest Information Update: 22 Oct 2016
At a glance
- Drugs Paclitaxel-hyaluronic acid conjugate (Primary)
- Indications Bladder cancer
- Focus Therapeutic Use
- Sponsors Fidia Farmaceutici
- 22 Oct 2016 This trial has been completed in Germany (end date: 4 Oct 2016).
- 11 Oct 2016 This trial was completed inn Spain (end date: 2016-10-04), according to European Clinical Trials Database.
- 15 Sep 2012 Planned end date changed from 17 Sep 2012 to 17 Sep 2013 as reported by European Clinical Trials Database record.